Total Valuation
ChemoMetec A/S has a market cap or net worth of kr10.21B. The enterprise value is kr6.01B.
Market Capkr10.21B
Enterprise Valuekr6.01B
Share Statistics
ChemoMetec A/S has 17,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,402,480
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ChemoMetec A/S’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 26.69%.
Return on Equity (ROE)0.28
Return on Assets (ROA)0.23
Return on Invested Capital (ROIC)26.69%
Return on Capital Employed (ROCE)0.34
Revenue Per Employee2.94M
Profits Per Employee1.44M
Employee Count174
Asset Turnover0.59
Inventory Turnover0.20
Valuation Ratios
The current PE Ratio of ChemoMetec A/S is 50.6. ChemoMetec A/S’s PEG ratio is ―.
PE Ratio50.6
PS Ratio0.00
PB Ratio0.00
Price to FCF0.00
Price to Operating Cash Flow48.50
PEG Ratio―
Income Statement
In the last 12 months, ChemoMetec A/S had revenue of 511.06M and earned 201.84M in profits. Earnings per share was 11.60.
Revenue511.06M
Gross Profit485.99M
Operating Income251.00M
Pretax Income258.17M
Net Income201.84M
EBITDA281.25M
Earnings Per Share (EPS)11.60
Cash Flow
In the last 12 months, operating cash flow was 210.36M and capital expenditures -28.31M, giving a free cash flow of 182.04M billion.
Operating Cash Flow210.36M
Free Cash Flow182.04M
Free Cash Flow per Share10.46
Dividends & Yields
ChemoMetec A/S pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-11.76%
50-Day Moving Average497.38
200-Day Moving Average444.34
Relative Strength Index (RSI)67.65
Average Volume (3m)8.43K
Important Dates
ChemoMetec A/S upcoming earnings date is Feb 3, 2027, TBA (Not Confirmed).
Last Earnings DateSep 10, 2026
Next Earnings DateFeb 3, 2027
Ex-Dividend Date―
Financial Position
ChemoMetec A/S as a current ratio of 4.09, with Debt / Equity ratio of 0.63%
Current Ratio4.09
Quick Ratio3.11
Debt to Market Cap<0.01
Net Debt to EBITDA-1.02
Interest Coverage Ratio640.29
Taxes
In the past 12 months, ChemoMetec A/S has paid 56.34M in taxes.
Income Tax56.34M
Effective Tax Rate0.22
Enterprise Valuation
ChemoMetec A/S EV to EBITDA ratio is 21.39, with an EV/FCF ratio of 33.05.
EV to Sales11.77
EV to EBITDA21.39
EV to Free Cash Flow33.05
EV to Operating Cash Flow28.60
Balance Sheet
ChemoMetec A/S has kr293.56M in cash and marketable securities with kr7.78M in debt, giving a net cash position of kr288.97M billion.
Cash & Marketable Securitieskr293.56M
Total Debtkr7.78M
Net Cashkr288.97M
Net Cash Per Sharekr16.61
Tangible Book Value Per Sharekr29.73
Margins
Gross margin is 64.30%, with operating margin of 49.11%, and net profit margin of 39.49%.
Gross Margin64.30%
Operating Margin49.11%
Pretax Margin50.52%
Net Profit Margin39.49%
EBITDA Margin55.03%
EBIT Margin49.11%
Analyst Forecast
The average price target for ChemoMetec A/S is kr500.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Targetkr500.00
Price Target Upside5.26% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast3.12%
EPS Growth Forecast8.31%